Cargando…

High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin

A translational need exists to understand and predict vancomycin‐induced kidney toxicity. We describe: (i) a vancomycin high‐performance liquid chromatography (HPLC) method for rat plasma and kidney tissue homogenate; (ii) a rat pharmacokinetic (PK) study to demonstrate utility; and (iii) a catheter...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, MD, O'Donnell, JN, Venkatesan, N, Chang, J, Nguyen, H, Rhodes, NJ, Pais, G, Chapman, RL, Griffin, B, Scheetz, MH
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698807/
https://www.ncbi.nlm.nih.gov/pubmed/28675684
http://dx.doi.org/10.1111/cts.12484
_version_ 1783280831258689536
author Joshi, MD
O'Donnell, JN
Venkatesan, N
Chang, J
Nguyen, H
Rhodes, NJ
Pais, G
Chapman, RL
Griffin, B
Scheetz, MH
author_facet Joshi, MD
O'Donnell, JN
Venkatesan, N
Chang, J
Nguyen, H
Rhodes, NJ
Pais, G
Chapman, RL
Griffin, B
Scheetz, MH
author_sort Joshi, MD
collection PubMed
description A translational need exists to understand and predict vancomycin‐induced kidney toxicity. We describe: (i) a vancomycin high‐performance liquid chromatography (HPLC) method for rat plasma and kidney tissue homogenate; (ii) a rat pharmacokinetic (PK) study to demonstrate utility; and (iii) a catheter retention study to enable future preclinical studies. Rat plasma and pup kidney tissue homogenate were analyzed via HPLC for vancomycin concentrations ranging from 3–75 and 15.1–75.5 μg/mL, respectively, using a Kinetex Biphenyl column and gradient elution of water with 0.1% formic acid: acetonitrile (70:30 v/v). Sprague‐Dawley rats (n = 10) receiving 150 mg/kg of vancomycin intraperitoneally had plasma sampled for PK. Finally, a catheter retention study was performed on polyurethane catheters to assess adsorption. Precision was <6.1% for all intra‐assay and interassay HPLC measurements, with >96.3% analyte recovery. A two‐compartment model fit the data well, facilitating PK exposure estimates. Finally, vancomycin was heterogeneously retained by polyurethane catheters.
format Online
Article
Text
id pubmed-5698807
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56988072017-11-30 High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin Joshi, MD O'Donnell, JN Venkatesan, N Chang, J Nguyen, H Rhodes, NJ Pais, G Chapman, RL Griffin, B Scheetz, MH Clin Transl Sci Research A translational need exists to understand and predict vancomycin‐induced kidney toxicity. We describe: (i) a vancomycin high‐performance liquid chromatography (HPLC) method for rat plasma and kidney tissue homogenate; (ii) a rat pharmacokinetic (PK) study to demonstrate utility; and (iii) a catheter retention study to enable future preclinical studies. Rat plasma and pup kidney tissue homogenate were analyzed via HPLC for vancomycin concentrations ranging from 3–75 and 15.1–75.5 μg/mL, respectively, using a Kinetex Biphenyl column and gradient elution of water with 0.1% formic acid: acetonitrile (70:30 v/v). Sprague‐Dawley rats (n = 10) receiving 150 mg/kg of vancomycin intraperitoneally had plasma sampled for PK. Finally, a catheter retention study was performed on polyurethane catheters to assess adsorption. Precision was <6.1% for all intra‐assay and interassay HPLC measurements, with >96.3% analyte recovery. A two‐compartment model fit the data well, facilitating PK exposure estimates. Finally, vancomycin was heterogeneously retained by polyurethane catheters. John Wiley and Sons Inc. 2017-07-04 2017-11 /pmc/articles/PMC5698807/ /pubmed/28675684 http://dx.doi.org/10.1111/cts.12484 Text en © 2017 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research
Joshi, MD
O'Donnell, JN
Venkatesan, N
Chang, J
Nguyen, H
Rhodes, NJ
Pais, G
Chapman, RL
Griffin, B
Scheetz, MH
High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin
title High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin
title_full High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin
title_fullStr High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin
title_full_unstemmed High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin
title_short High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin
title_sort high‐performance liquid chromatography method for rich pharmacokinetic sampling schemes in translational rat toxicity models with vancomycin
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698807/
https://www.ncbi.nlm.nih.gov/pubmed/28675684
http://dx.doi.org/10.1111/cts.12484
work_keys_str_mv AT joshimd highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin
AT odonnelljn highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin
AT venkatesann highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin
AT changj highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin
AT nguyenh highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin
AT rhodesnj highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin
AT paisg highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin
AT chapmanrl highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin
AT griffinb highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin
AT scheetzmh highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin